Looks like no one added any tags here yet for you.
Common cold
viral infection of the upper respiratory tract
most common viral infection within the upper respiratory tract
Rhinoviruses
types of rhinoviruses
parainfluenza viruses, respiratory syncytial virus, coronaviruses, and adenoviruses
Transmission of Common Cold
Fingers are the greatest source of spread
• Nasal mucosa and conjunctiva are most common portals of entry
clinical manifestations of the common cold
dryness and stuffiness
runny nose, tearing, usually clear, postnasal get, sore throat and horseness
headache, malaise, may have fever/chills
treatment of the common cold
symptomatic
vitamin C shortens duration( if you take it prior to it but doesn’t prevent it)
rhino sinusitis
inflammation of the paranasal sinuses
infection or allergy obstructs sinus drainage
signs and symptoms of rhino sinusitis
facial pain( bending forward, coughing, sneezing exaggerates)
nasal obstruction, fullness in the ears, postnasal drip, hoarseness, chronic cough, loss of taste and smell, unpleasant breath, headache
acute rhino sinusitis
may last from 5-7 days up to 4 week
Viral: rhinovirus, influenza, and parainfluenza
• Bacterial: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrha
subacute rhino sinusitis
lasts from 4 weeks to less than 12 week
chronic rhino sinusitis
lasts beyond 12 weeks
Bacterial: Staphylococcus aureus and anaerobic bacteria
neutropenic patients
fungi and pseudomonas aeruginosa
treatment of rhinosinusitis
depends on the cause
pneumonia
inflammation of parenchymal structures of the lung
alveoli and bronchioles
pneumonia is the…
8th leading cause of death
(higher in elderly and debilitated
pneumonia infectious factors
bacteria, fungal, viral
pneumonia non-infectious factors
aspiration, toxic fumes
typical pneumonia
alveolar infiltration
bacterial
-pneumonia
-haemophilus influenza
-staph aureus
atypical pneumonia
no alveolar infiltration
symptoms of typical pneumonia
fever, chills, productive cough, pleuritic chest pain
crackles, dullness to percussion, ego phony, increased fremitus
symptoms of atypical pneumonia
fever, dyspnea, malaise, headache, dry cough
few findings
Pneumococcal Pneumonia
caused by S. pneumoniae (+diplococci)
most common cause of bacterial pneumonia
immune response of pneumococcal pneumonia
Capsule elicits humoral response (antibodies)
• Reticuloendothelial system (macrophages from spleen)
• Asplenic individuals highly susceptible
who should get the pneumococcal vaccine?
> 65 years
• Immunocompromised
• Chronic illnesses
• Asplenic( they have no spleen)
walking pneumonia
atypical pneumonia due to it being mild and having a low mortality rate
what is atypical most common for?
children and young adults
pathogen in atypical pneumonia
Mycoplasma pneumoniae, Chlamydia pneumoniae
• Viruses (influenza virus, RSV, adenovirus, rhinoviruses, rubeola, varicella)
lobar lung involvement
affect only one lobe of the lung
• Typical pneumonia
bronchopneumonia
patchy distribution
• Atypical pneumonia
community pneumonia
Acquired outside hospital or
nursing home
• Diagnosed within 48hr of
admission
hospital pneumonia
2nd most common infection
20-30% mortality rate
higher in immunocompromised people
after the patient has been admitted for 48 hours
diagnosis of pneumonia
H/ P
chest X-ray
antibiotics if bacterial for pneumonia
Match the bug to the drug
• Early treatment is best
symptomatic of pneumonia
Hydration
• Antipyretics/Analgesics
• Positioning: Good lung down
• O2/IS
• Cough/Deep breathing
influenza
causes acute upper respiratory tract infection
All viruses undergo continuous mutation and
evolution
virus of influenza
Orthomyxoviridae
• Segmented, single-stranded RNA
• Surface antigens
• Hemagglutinin
• Neuraminidase
types of influenza
influenza A
influenza B
influenza C
when a patient had pneumonia what you do you?
put the good lung down
influenza A
Infects mammalian and avian species
• Can develop new HA and NA subtypes
• Antigenic shift (e.g.- H1N1; H5N1)
• Antigenic drift
is influenza more contagious than bacterial RTI?
yes
transmission of influenza
inhaled droplet transmission
incubation period of influenza
1-4 days
pathogenesis of influenza
Uncomplicated upper respiratory infection
(rhinotracheitis)
• Targets and kills mucous-secreting, ciliated epithelial cells
> ECF escape
viral pneumonia
shedding of bronchial and alveolar cells
antigenic shift
when the bacteria is changed completely
viral to bacterial respiratory infection
Compromise of natural defenses of respiratory tract >
bacterial adhesion
• Can lead to pneumonia
early influenza A or B
abrupt onset of fever
• Chills
• Rigors
• Malaise
• Muscle ache
• Headache
• Profuse watery nasal
discharge
• Nonproductive cough
• Sore throat
early influenza C
common cold symptoms
complications of influenza
Viral Pneumonia
• Develops 1 day after
onset of influenza
• Rapid progression of
clinical course
• Hypoxemia
• Death
• Diffuse pulmonary
fibrosis
secondary complications of influenza
Sinusitis
• Otitis media
• Bronchitis
• Bacterial pneumonia
• S. pneumoniae
• S. aureus
• H. influenzae
• Moraxella catarrhalis
• Reye syndrome
• Aspirin use in young
children
diagnosis of influenza
rapid diagnostic test
treatment of influenza
Rest
• Managing fever
• Staying hydrated
• Analgesic and cough medication
• Antiviral drugs
influenza vaccine
antigenic changes require a new formulation every year (bc of mutations)
vaccines of influenza
quadrivalent Inactivated influenza vaccine (QIIV):
• IM
• Live, attenuated influenza vaccine (LAIV):
• inhaled intranasally
• Between ages 2-49
• Uncommon adverse effects
• Guillain-Barré, flu symptoms, myalgia
peak flu season
usually January/ February
when is it best to get vaccinated?
October or November
latest you can get vaccinated?
April
can it be given at the same time as other vaccines?
yes you can
when is the influenza vaccine effective?
1-2 weeks after vaccination
lasts about 6 month and depends on health of patient
who should get influenza vaccine?
Anyone 6 months and older
• At risk for complications
• Elderly
• Immunocompromised
• Chronic illness
• Healthcare workers
• Teachers
• Safe in pregnancy
who shouldn’t get the influenza vaccine?
past reactions
Gillian-barre( autoimmune disorder where body affects myelin)
current febrile illness (fever)
causative factors of cancer
Smoking (80%)
• Asbestos
• Familial predisposition
4 major categories
squamous cell lung carcinoma (25-40%)
• Adenocarcinoma (20 – 40%)
• Small cell carcinoma (20 – 25%)
• Large cell carcinoma (10 – 15%)
small cell lung cancer
Small, round to oval cells the size of a lymphocyte that grow in
clusters
• Cells may arise from neuroendocrine cells of the bronchial epithelium
• Strongest association with cigarette smoking
• Highly malignant
• Brain metastasis often provides the first evidence of the tumor
• No good surgical options
• Associated with paraneoplastic syndrome:
• SIADH
• Cushing syndrome (ectopic production of ACTH)
non-small cell lung cancer
Capacity to synthesize bioactive products and
produce paraneoplastic syndromes (like SCLC
Squamous cell carcinomas
Most common in men w/ close correlation with
smoking history
• Paraneoplastic syndrome: hypercalcemia
Adenocarcinomas
Most common type of lung cancer in North America
• Most common type of lung cancer in women and
nonsmokers
Poorer prognosis than squamous cell carcinomas
Large cell carcinomas
Poor prognosis d/t spread to distant sites early in
course
clinical manifestations of lung cancer
symptoms
• Anorexia
• Weight loss
• Symptoms that are similar to chronic bronchitis (often disregarded)
• Chronic cough
• Shortness of breath
• Wheezing
• Hemoptysis (blood in sputum)
• Chest pain
• Metastasis
• Brain, Bone, Liver
diagnosis of lung cancer
H/P
• Chest x-ray
• Bronchoscopy
• Cytology of sputum or bronchial
washings
• Percutaneous needle biopsy of
lung tissue
• CT scan, MRI, and ultrasound used
to locate lesions
treatment of lung cancer
NSCLC
• Surgery- removal of small, localized NSCLC tumors
• Radiation therapy
• Main treatment modality
• Part of combined treatment
• Palliative
• Chemotherapy- usually combination chemotherapy used
• SCLC
• Chemotherapy
• Radiation Therapy
• Prophylactic cranial irradiation (metastasis to brain)
tuberculosis
Mycobacterium tuberculosis is
an aerobic bacilli
• Protective waxy capsule
• Can remain dormant for years
transmission of tuberculosis
Expelled with coughing,
sneezing, shouting, or singing
• Spreads via droplet nuclei
• Airborne precautions
people at higher risk for TB
Close contacts
• Foreign-born persons from areas where TB is common
• Persons who visit TB-prevalent countries
• Residents and employees of high-risk congregate settings
• Health care workers (HCWs) who serve high-risk clients
• Children and adolescents exposed to adults at increased risk for
infection or disease
TB infection
Granulomatous lesion
• Macrophages
• T cells
• Fibroblasts
• Inactive TB bacteria
• Cell mediated immunity
• Pathogenesis is from immune response
• Caseous necrosis
hon necrosis
more common in sub pleural area
TB infection duration
takes 3-6 weeks to develop + TB test
usually lies dormant making it non infectious
risk of developing TB for normal immune system that untreated
5% develop TB in first 1–2 years post infection
• Another 5% later in life
risk of developing Tb for immunocompromised
7%–10% each year
• Children <5 years of age also at increased risk
person infected with TB( non infectious)
Small amount TB bacteria are alive, inactive
Cannot spread TB bacteria to others
Does not feel sick, but may become sick if the
bacteria become active
TB skin test or TB blood test reaction indicating TB
infection
Radiograph is typically normal
Sputum smears and cultures are negative
Should consider treatment for LTBI to prevent TB
disease
Does not require respiratory isolation
Not a TB case
person with TB disease( infectious)
large amount of active TB bacteria
May spread TB bacteria to others
may feel sick and may have symptoms such as cough, fever, or weight loss
TB skin test or TB blood test reaction indicating TB infection
radiograph may be abnormal
sputum smears and cultures may be positive
needs treatment for TB disease
respiratory isolation
a TB case
TB screening
Tuberculin skin test (PPD)
• Mantoux tuberculin skin test (TST)
• Inject 0.1 ml of PPD (5 tuberculin
units) into forearm between skin
layers
reading TST
takes 3-6 weeks after exposure to react to PPD
read 48-72 hours after infection
palpate injection site
measure diameter of induration across forearm
record size of induration in millimeters
record “0” if no induration found
Interpreting TST
≥5 mm induration is classified as positive in
• HIV-infected persons
• Patients with organ transplants and other immunosuppressed patients
• Recent contacts of infectious TB
• Persons with fibrotic changes on chest radiograph consistent with prior TB
• ≥10 mm induration is classified as positive in
• Recent arrivals from high-prevalence countries
• Residents and employees of high-risk congregate settings
• Mycobacteriology laboratory personnel
• Persons with conditions that increase risk for progressing to TB
Pregnant Women
TST is safe and reliable for
mother and fetus throughout
pregnancy
• Give TST to pregnant women
who have risk factors for
infection or disease
BCG Vaccine
Vaccine made from live, attenuated (weakened) strain of M. bovis
• Early version first given to humans in 1921
• Many TB-prevalent countries vaccinate infants
• BCG not generally recommended in the U.S
Interferon Gamma Release
Assays (IGRAs)
Quintiferon or T-Spot
• Blood draw
• Cannot differentiate between TB
and LTBI; other tests needed
• May be used in place of, but not in
addition to, TST
• Preferred when testing persons
• Who might not return for TST
reading
• Who have received BCG vaccination
Signs and Symptoms of TB
Prolonged cough (3 weeks or longer), hemoptysis
• Chest pain
• Loss of appetite, unexplained weight loss
• Night sweats, fever
• Fatigue
Diagnosis of TB
sputum culture
• gold standard for diagnosis
• Acid fast stain
• Chest x-ray
Treatment of Tuberculosis
• Latent TB is treated with just one or two drugs
• Active TB
• Isoniazid, Rifampin, Ethambutol, Pyrazinamide
• Eliminate tubercle bacilli and avoid emergence of
drug resistance
• DOT- direct observation therapy
• Can dose 2-3X / wk
Evaluating Treatment of TB
Bacteriologic evaluation of sputum
• With proper drug selection – 90% of patients negative after 3 months
• Clinical evaluation
• Monitor fever, malaise, anorexia, cough
• Should decrease within 2 weeks
• CXR
• Should show improvement in 3 months
Respiratory distress syndrome
(RDS
Hyaline membrane disease
• Premature infants
• Type II alveolar cells produce
surfactant
• Matures at 25-28th week of gestation
• Reduced surface tension
• Difficulty breathing
• Formation of hyaline membrane
• Reduced gas exchange hypoxemia
and CO2 retention
Manifestations of respiratory distress syndrome
Signs of respiratory distress in first 24 hours after
birth
• Central cyanosis, SOB, retractions
• Grunting with expiration
• Fatigue
treatment of respiratory distress syndrome
Supportive care
• Incubator or warmer use
• O2
• Mechanical ventilation
• Exogenous surfactant therapy
Epiglottitis
Dramatic, potentially fatal condition
• Most common causative agent
• Haemophilus influenzae B
• Sudden onset
signs and symptoms of epiglottis
Sits with mouth open and chin thrust forward
• Do not force child to lay flat
• Low-pitched stridor, difficulty swallowing, fever, drooling, anxiet
treatment of epiglottis
Intubation or tracheotomy
• Treatment with appropriate antibiotics
croup
Viral infection that affects the larynx, trachea, and bronchi
• Parainfluenza virus (75%)
• Preceded by upper respiratory infection
signs and symptoms of croup
Stridor and a wet, barking cough
• Usually occurs at night
• Relieved by exposure to cold or moist ai
treatment of croup
Mist tent
• Nebulization if not relieved by exposure to moist air
• Oxygen